Raymond James Financial
MD icon

Raymond James Financial’s Pediatrix Medical MD Stock Holding History

Raymond James Financial’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Buy
563,461
+108,715
+24% +$2.47M ﹤0.01% 1832
2026
Q1 		$9.73M Buy
454,746
+179,834
+65% +$3.74M ﹤0.01% 2046
2025
Q4 		$5.88M Buy
274,912
+27,490
+11% +$563K ﹤0.01% 2384
2025
Q3 		$4.14M Sell
247,422
-180
-0.1% -$2.7K ﹤0.01% 2597
2025
Q2 		$3.55M Buy
247,602
+11,279
+5% +$155K ﹤0.01% 2618
2025
Q1 		$3.42M Buy
236,323
+2,666
+1% +$37.9K ﹤0.01% 2596
2024
Q4 		$3.07M Buy
+233,657
New +$3.23M ﹤0.01% 2652

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Raymond James Financial's MD Position: Q2 2026 in Review

Raymond James Financial increased its Pediatrix Medical (MD) stake by 24% in Q2 2026, buying an estimated $2.47M and bringing the position to 563,461 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1832.

Raymond James Financial first reported a position in MD in Q4 2024 and has held it in 7 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Raymond James Financial held 563,461 shares of Pediatrix Medical worth $14.3M as of Q2 2026.
  • Raymond James Financial bought 108,715 Pediatrix Medical shares in Q2 2026, an estimated $2.47M.
  • Pediatrix Medical made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1832 holding.
  • Raymond James Financial first reported a position in Pediatrix Medical in Q4 2024 and has held it in 7 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.